Explore the University Our Future Demands
Biology Assistant Professor Todd Castoe is the lead author on a new paper that details the sequencing of the Burmese python genome.
A National Institutes of Health grant is helping bioengineers develop a nanoparticle drug-delivery system designed to spur lung growth and function after partial lung removal or destructive lung disease.
UT Arlington scientists and engineers are making water safer by developing methods to analyze its quality, monitor biological toxins, and protect oceans against climate change.
According to a national survey, 4.1 million Americans sought treatment for drug addiction in 2010. Using cellular, molecular, and behavioral procedures, Linda Perrotti is exploring why some people become addicts while others don't.
Wayward cancer cells often cause tumors elsewhere in the body. Bioengineering Professor Liping Tang is creating a bone marrow-mimicking trap to attract these cells and confine them to a single location.
UT Arlington's capacity to explore the growing field of optics is expanding. A $500,000 endowment established through a gift from Nelson Claytor creates a distinguished professorship in honor of his father, Richard Claytor.
As energy demand rises, the electrical grid in the United States is steadily pushed to its limits. Electrical engineering Professor Qilian Liang is developing a digitally enabled smart grid to help ease that burden.
UT Arlington's Center of Excellence for High Energy Physics has contributed to the Higgs boson search for almost two decades. Physicists believe the Higgs, often referred to as the “God particle,” gives matter in the universe its mass.
Two aerospace engineers have received a three-year NASA grant to study novel injector designs to support combustion at hypersonic speeds, aiming to reduce air travel times and make space access affordable.
A new study of water wells in and near the Barnett Shale shows elevated levels of potential contaminants closest to natural gas extraction sites. Shimadzu Distinguished Professor Kevin Schug leads the research team.